Clinical Trial Update: Primary Antibiotic Prophylaxis Using Co-trimoxazole to Prevent Spontaneous Bacterial Peritonitis in Cirrhosis [Phase 3]

View source ↗

Summary

Phase 3 trial updating the use of co-trimoxazole for primary antibiotic prophylaxis to prevent spontaneous bacterial peritonitis in cirrhosis.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Spontaneous Bacterial Peritonitis

Drugs mentioned

• Co-trimoxazole (trimethoprim-sulfamethoxazole)

Snippet

Sponsor: University College, London | Conditions: Spontaneous Bacterial Peritonitis | Phase 3 | Status: UNKNOWN